insulin lispro

Generic: insulin lispro

Labeler: eli lilly and company
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name insulin lispro
Generic Name insulin lispro
Labeler eli lilly and company
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

insulin lispro 100 [iU]/mL

Manufacturer
Eli Lilly and Company

Identifiers & Regulatory

Product NDC 0002-7737
Product ID 0002-7737_6329aa6b-3571-4196-83b0-fc99de56f3ab
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA020563
Listing Expiration 2026-12-31
Marketing Start 2020-02-12

Pharmacologic Class

Established (EPC)
insulin analog [epc]
Chemical Structure
insulin [chemical/ingredient]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00027737
Hyphenated Format 0002-7737

Supplemental Identifiers

RxCUI
242120 1652639 1926331
UNII
GFX7QIS1II
NUI
N0000004931 N0000175453

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name insulin lispro (source: ndc)
Generic Name insulin lispro (source: ndc)
Application Number BLA020563 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0002-7737-01) / 10 mL in 1 VIAL
source: ndc

Packages (1)

0002-7737-01 1 VIAL in 1 CARTON (0002-7737-01) / 10 mL in 1 VIAL

Ingredients (1)

insulin lispro (100 [iU]/mL)

Linked Drug Pages (1)

Insulin Lispro, Insulin Lispro Junior KwikPen, Insulin Lispro KwikPen ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6329aa6b-3571-4196-83b0-fc99de56f3ab", "openfda": {"nui": ["N0000004931", "N0000175453"], "unii": ["GFX7QIS1II"], "rxcui": ["242120", "1652639", "1926331"], "spl_set_id": ["97d5e596-aae1-42c9-ae89-c3780959c467"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0002-7737-01)  / 10 mL in 1 VIAL", "package_ndc": "0002-7737-01", "marketing_start_date": "20200212"}], "brand_name": "Insulin Lispro", "product_id": "0002-7737_6329aa6b-3571-4196-83b0-fc99de56f3ab", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [Chemical/Ingredient]"], "product_ndc": "0002-7737", "generic_name": "Insulin lispro", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Insulin Lispro", "active_ingredients": [{"name": "INSULIN LISPRO", "strength": "100 [iU]/mL"}], "application_number": "BLA020563", "marketing_category": "BLA", "marketing_start_date": "20200212", "listing_expiration_date": "20261231"}